Treatment of hepatocellular carcinoma: a cost analysis of yttrium-90 transarterial radioembolization versus sorafenib.
Sign Up to like & getrecommendations! Published in 2018 at "Future oncology"
DOI: 10.2217/fon-2017-0566
Abstract: AIM The aim was to evaluate cost-effectiveness of yttrium-90 transarterial radioembolization (TARE) in comparison to sorafenib treatment. PATIENTS & METHODS A single-center, retrospective, observational study was performed, 166 patients with intermediate-/advanced-stage hepatocellular carcinoma were treated with… read more here.
Keywords: hepatocellular carcinoma; yttrium transarterial; tare; treatment ... See more keywords
Predictability of the radiological response to Yttrium-90 transarterial radioembolization by dynamic magnetic resonance imaging-based radiomics analysis in patients with intrahepatic cholangiocarcinoma.
Sign Up to like & getrecommendations! Published in 2023 at "Diagnostic and interventional radiology"
DOI: 10.4274/dir.2023.222025
Abstract: PURPOSE The study aims to investigate the predictability of the radiological response in intrahepatic cholangiocarcinoma (iCC) patients undergoing Yttrium-90 transarterial radioembolization (TARE) with a combined model built on dynamic magnetic resonance imaging (MRI)-based radiomics and… read more here.
Keywords: intrahepatic cholangiocarcinoma; yttrium transarterial; radiological response; icc patients ... See more keywords